Related posts

3 Best U.S. Healthcare ETFs
Investor Insights

This summary was created by AI, based on 4 opinions in the last 12 months.

The reviews for Healthcare Leaders Income ETF suggest that it is a good option for investors looking for exposure to the healthcare sector. The covered call strategy adds to the yield, making it a potential choice for those seeking income. However, some experts caution that the growth of the ETF may be somewhat restrained by the covered call structure. Overall, the consensus is that it is a solid choice for long-term investors bullish on the healthcare sector.

Consensus
Bullish
Valuation
Fair Value
Similar
XLV, HHL-T
HOLD

Good for healthcare exposure with dividend. Won't get high capital gains. But is a reliable product. 

E.T.F.'s
COMMENT

Blue-chip basket of US healthcare names. Covered calls and leverage. Covered calls trade potential upside for potential income. If investor's ACB has gone down, could be because of return of capital.

E.T.F.'s
DON'T BUY

The Harvest covered call ETFs start well, but then flatline. So, he has sold all his Harvest ETFs.

E.T.F.'s
TOP PICK

Healthcare sector lagging in the market, and is due for an increase in value. Very large companies with tailwind in aging population/demand for healthcare. Covered call strategy adds to yield. Good option for investors going forward. 

E.T.F.'s
PAST TOP PICK
(A Top Pick May 19/22, Up 6%)

It was strictly a yield play when interest rates were so low. He has only a small position. Growth in the ETF can be somewhat restrained by the covered call structure. It's a tradeoff between yield and growth. He's still bullish on the healthcare sector, the demographics are beautiful.

E.T.F.'s
BUY

Very good for healthcare exposure.
Actively managed with good performance.
High dividend yield (~10%).
Good for long term investors.

E.T.F.'s
DON'T BUY
Covered call. Equal weight basket of mainly 20 US healthcare names. Yield is 8.5%. MER of 99 bps, not as cheap as some of the others. He prefers, and owns, IXJ. IXJ is a basket of global healthcare names, with only a 40 bps MER.
E.T.F.'s
BUY
It's a covered call US healthcare ETF. HC is a growth sector. HHL pays over an 8% dividend, so it's very attractive. The one-year chart shows little growth, so you buy this for the yield. Tailwind: the baby boomers are getting older, and there's a huge backlog of surgeries built up during Covid. Plus immigration. HC is definitely a growth area.
E.T.F.'s
BUY
Good ETF for healthcare exposure (USA and international). Dividend does not qualify for Canadian divided tax credit. Look into tax treatment for each situation.
E.T.F.'s
BUY
Allan Tong’s Discover Picks Among the caveats here is that HHL doesn't offer much growth. HHL is currently trading 30 cents above its 2022 low of $7.55, but its high is only $9.05. If you buy at current levels, add the dividend and subtract the MER, you're collecting a 13.5% return over a year. Not bad in these volatile times. Read 3 Best U.S. Healthcare ETFs for our full analysis.
E.T.F.'s
Unspecified
It is a very large cap fund. Does some covered writing which gives away some upside. Whether you buy or not depends on your view of the health care space. It is 40% pharmaceuticals, 19% health care supplies, 15% health care services.
E.T.F.'s
BUY
Believes healthcare sector is good for investors looking for yield (demand not going away). Not a growth story, but will provide stability.
E.T.F.'s
BUY
Interesting company due to strong yield. Main issue is not as strong of growth as other stocks. Return has been strong regardless. Good for investors looking for income, but not growth.
E.T.F.'s
BUY

Invests in healthcare issuers, a space he likes. Healthcare offers growth and defence and does well in late cycles and recessions. Pays enhanced dividends, too, with options totalling 8.7% dividends. The MER is around 1%, which is a little high. Covered calls do well in flat or down markets. Covered calls are also very tax efficient.

E.T.F.'s
BUY ON WEAKNESS

HHL-T vs ZEB-T Canadian banks good long-term investment. European banks good as well. Canada doesn't have much exposure to healthcare stocks but they're going to be part of the future. HHL could be a way to play that. Have to think diversified. Good to make room for both of them in your portfolio.

E.T.F.'s
Showing 1 to 15 of 77 entries

Healthcare Leaders Income ETF(HHL-T) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for Healthcare Leaders Income ETF is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Healthcare Leaders Income ETF(HHL-T) Frequently Asked Questions

What is Healthcare Leaders Income ETF stock symbol?

Healthcare Leaders Income ETF is a Canadian stock, trading under the symbol HHL-T on the Toronto Stock Exchange (HHL-CT). It is usually referred to as TSX:HHL or HHL-T

Is Healthcare Leaders Income ETF a buy or a sell?

In the last year, 2 stock analysts published opinions about HHL-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Healthcare Leaders Income ETF.

Is Healthcare Leaders Income ETF a good investment or a top pick?

Healthcare Leaders Income ETF was recommended as a Top Pick by on . Read the latest stock experts ratings for Healthcare Leaders Income ETF.

Why is Healthcare Leaders Income ETF stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Healthcare Leaders Income ETF worth watching?

2 stock analysts on Stockchase covered Healthcare Leaders Income ETF In the last year. It is a trending stock that is worth watching.

What is Healthcare Leaders Income ETF stock price?

On 2024-07-12, Healthcare Leaders Income ETF (HHL-T) stock closed at a price of $8.4.